Humam Kadara

Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

Ferdinandos Skoulidis, Lauren A. Byers, Lixia Diao et al. · Cancer Discovery · 2015 · 916 citations · Full text

Medicine, Immunology, Oncology +17

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 604 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

Yanshuo Chu, Enyu Dai, Yating Li et al. · Nature Medicine · 2023 · 485 citations · Full text

Medicine, Cancer Biology, Oncology +14

Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells

Ashutosh Pathak, Manisha Bhutani, S. Asha Nair et al. · Molecular Cancer Research · 2007 · 234 citations

Medicine, Oncology, Pharmacology +14

Comprehensive T cell repertoire characterization of non-small cell lung cancer

Alexandre Reuben, Jiexin Zhang, Shin‐Heng Chiou et al. · Nature Communications · 2020 · 229 citations · Full text

Life Sciences, Immunology, Oncology +17